The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Role of interleukin‐4 and interleukin‐10 in murine collagen‐induced arthritis. Protective effect of interleukin‐4 and interleukin‐10 treatment on cartilage destruction
Open accessAbstract
Objective. To examine the role of endogenous interleukin‐4 (IL‐4) and interleukin‐10 (IL‐10) and the therapeutic effect of the addition of IL‐4 and IL‐10 in early and established murine collagen‐induced arthritis (CIA). Methods. Murine recombinant IL‐4, IL‐10, or the combination was given intraperitoneally twice daily from the day of arthritis onset up to 7–10 days of CIA in DBA/1 mice. Anti‐IL‐4, anti–IL‐10, or both antibodies were given intraperitoneally before or after the onset of CIA. The effect of cytokine or anticytokine treatment was monitored visually by macroscopic scoring. Histology and reverse transcription‐polymerase chain reaction (RT‐PCR) analyses were performed at the end of the treatment period. Results. IL‐4 alone did not provoke any effect, IL‐10 slightly suppressed the arthritis, but a more pronounced amelioration was found with the combination. This cooperative effect was noted after early treatment but also occurred when the start of treatment was delayed until 1 week after onset. Apart from suppression of macroscopic signs of inflammation, combined treatment with IL‐4/IL‐10 also reduced cellular infiltrates in the synovial tissue and caused pronounced protection against cartilage destruction. Moreover, levels of mRNA for tumor necrosis factor α (TNFα) and IL‐1 were highly suppressed both in the synovial tissue and in the articular cartilage. In contrast, levels of IL‐1 receptor antagonist (IL‐1Ra) mRNA remained elevated, which suggests that the mechanism of protection may be related to suppressed production of TNFα and IL‐1, with concomitant up‐regulation of the IL‐1Ra/IL‐1 balance. However, accelerated onset of CIA and increased severity could be achieved with neutralizing anti–IL‐10 antibodies. This expression could be further optimized with a combination of anti–IL‐4 and anti–IL‐10 antibodies, although anti–IL‐4 alone was without effect. Conclusion. Our data are consistent with a dominant role of IL‐10 in the natural suppression of arthritis expression, whereas combined treatment with IL‐4 and IL‐10 appears of potential therapeutic value, not only at the onset, but also in established arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Quantitation of mRNA by the polymerase chain reaction.
Wang, A. M., Doyle, M. V., & Mark, D. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9717 · Cited by 1,625
Autoimmunity to type II collagen an experimental model of arthritis.
Trentham, D. E., Townes, A. S., & Kang, A. H. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.3.857 · Cited by 1,603
Immunisation against heterologous type II collagen induces arthritis in mice
Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A., & Mosedale, B. (1980) · Nature · doi:10.1038/283666a0 · Cited by 1,025
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S. K., Sims, J. E., & Mantovani, A. (1993) · Science · doi:10.1126/science.8332913 · Cited by 980
Arend, W. P., & Dayer, J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380202 · Cited by 891
Gérard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., Fiers, W., Goldman, M., & Velu, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.547 · Cited by 796
Self-citation[2] Preparation and characterization of the different types of collagen
Miller, E. J., & Kent Rhodes, R. (1982) · Methods in Enzymology · doi:10.1016/0076-6879(82)82059-4 · Cited by 752
Hart, P. H., Vitti, G. F., Burgess, D. R., Whitty, G. A., Piccoli, D. S., & Hamilton, J. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3803 · Cited by 742
Interleukin (IL)-10 Inhibits Nuclear Factor кB (NFкB) Activation in Human Monocytes
Wang, P., Wu, P., Siegel, M. I., Egan, R. W., & Billah, M. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9558 · Cited by 711
Berg, D. J., Kühn, R., Rajewsky, K., Müller, W., Menon, S., Davidson, N., Grünig, G., & Rennick, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118290 · Cited by 535
Ishida, H., Muchamuel, T., Sakaguchi, S., Andrade, S., Menon, S., & Howard, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.305 · Cited by 532
Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
Katsikis, P. D., Chu, C. Q., Brennan, F. M., Maini, R. N., & Feldmann, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1517 · Cited by 529
(2008) · Arthritis & Rheumatism · doi:10.1002/art.23363 · Cited by 505
Diversity in the contribution of interleukin‐10 to T‐cell‐mediated immune regulation
Maynard, C. L., & Weaver, C. T. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00711.x · Cited by 402
Joosten, L. A. B., Helsen, M. M. A., van de Loo, F. A. J., & van den Berg, W. B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390513 · Cited by 400
Self-citationResistance to fever induction and impaired acute-phase response in interleukin-1β-deficient mice
Zheng, H., Fletcher, D., Kozak, W., Jiang, M., Hofmann, K. J., Corn, C. A., Soszynski, D., Grabiec, C., Trumbauer, M. E., Shaw, A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90154-x · Cited by 365
Thorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M., & Palladino, M. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7375 · Cited by 360
Connors, M., Giese, N. A., Kulkarni, A. B., Firestone, C. Y., Morse, H. C., & Murphy, B. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5321-5325.1994 · Cited by 348
Vannier, E., Miller, L. C., & Dinarello, C. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4076 · Cited by 321
Cassatella, M. A., Meda, L., Gasperini, S., Calzetti, F., & Bonora, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1695 · Cited by 284
Hu-Li, J., Ohara, J., Watson, C., Tsang, W., & Paul, W. E. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.3.800 · Cited by 279
Kasama, T., Strieter, R. M., Lukacs, N. W., Lincoln, P. M., Burdick, M. D., & Kunkel, S. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117993 · Cited by 270
Interleukin‐10 inhibition of the progression of established collagen‐induced arthritis
Walmsley, M., Katsikis, P. D., Abney, E., Parry, S., Williams, R. O., Maini, R. N., & Feldmann, M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390318 · Cited by 261
Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts.
Bucala, R., Ritchlin, C., Winchester, R., & Cerami, A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.569 · Cited by 261
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment
VAN DEN BERG, W. B., JOOSTEN, L. A. B., HELSEN, M., & VAN DE LOO, F. A. J. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06517.x · Cited by 251
Self-citationElevated interleukin-10 levels in patients with rheumatoid arthritis: ELEVATED IL-10 RA PATIENTS
Cush, J. J., Splawski, J. B., Thomas, R., Mcfarlin, J. E., Schulze-Koops, H., Davis, L. S., Fujita, K., & Lipsky, P. E. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380115 · Cited by 249
Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses.
Berg, D. J., Leach, M. W., Kühn, R., Rajewsky, K., Müller, W., Davidson, N. J., & Rennick, D. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.99 · Cited by 239
RANKIN, E. C. C., CHOY, E. H. S., KASSIMOS, D., KINGSLEY, G. H., SOPWTTH, A. M., ISENBERG, D. A., & PANAYI, G. S. (1995) · Rheumatology · doi:10.1093/rheumatology/34.4.334 · Cited by 231
In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp‐lpr/lpr mouse
Murray, L. J., Lee, R., & Martens, C. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200124 · Cited by 215
Chomarat, P., Vannier, E., Dechanet, J., Rissoan, M. C., Banchereau, J., Dinarello, C. A., & Miossec, P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1432 · Cited by 194
Stuart, J. M., Townes, A. S., & Kang, A. H. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110495 · Cited by 188
Jenkins, J. K., Malyak, M., & Arend, W. P. (1994) · PubMed · Cited by 181
Allen, J. B., Wong, H. L., Costa, G. L., Bienkowski, M. J., & Wahl, S. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.8.4344 · Cited by 168
Protective effects of IL-4 and IL-10 against immune complex-induced lung injury.
Mulligan, M. S., Jones, M. L., Vaporciyan, A. A., Howard, M. C., & Ward, P. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.10.5666 · Cited by 158
Nasrin, N., Ercolani, L., Denaro, M., Kong, X. F., Kang, I., & Alexander-Bridges, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5273 · Cited by 148
Hart, P. H., Ahern, M. J., Smith, M., & Finlay‐Jones, J. J. (1995) · PubMed Central · Cited by 104
Pradier, O., Gerard, C. M., Delvaux, A., Lybin, M., Abramowicz, D., Capel, P., Velu, T. J., & Goldman, M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231048 · Cited by 98
Self-citationParadoxical effects of IL-10 in endotoxin-induced uveitis
Rosenbaum, J. T., & Angell, E. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.4090 · Cited by 83
Interleukin-4 is a critical cytokine in contact sensitivity.
Salerno, A., Dieli, F., Sireci, G., Bellavia, A., & Asherson, G. L. (1995) · PubMed · Cited by 71
Sugiyama, E., Kuroda, A., Taki, H., Ikemoto, M., Hori, T., Yamashita, N., Maruyama, M., & Kobayashi, M. (1995) · PubMed · Cited by 54
Dieli, F., Asherson, G. L., Romano, G. C., Sireci, G., Gervasi, F., & Salerno, A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.6.2698 · Cited by 52
Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants.
Yeh, L.-A., Augustine, A., Lee, P., Riviere, L. R., & Sheldon, A. (1995) · PubMed · Cited by 45
Cope, A. P., Gibbons, D. L., Aderka, D., Foxwell, B. M. J., Wallach, D., Maini, R. N., Feldmann, M., & Brennan, F. M. (1993) · Cytokine · doi:10.1016/1043-4666(93)90006-q · Cited by 37
Role of IL-2 and IL-4 in exacerbations of murine antigen-induced arthritis.
Jacobs, M. J. M., Hoek, A., van Lent, P. L. E. M., van de Loo, F. A. J., van de Putte, L. B. A., & van den Berg, W. B. (1994) · PubMed · Cited by 34
Self-citationChensue, S. W., Bienkowski, M., Eessalu, T. E., Warmington, K. S., Hershey, S. D., Lukacs, N. W., & Kunkel, S. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3654 · Cited by 31
A sensitive and specific bioassay for the detection of human interleukin-10
Schlaak, J., Schmitt, E., Hüls, C., Büschenfelde, K. H. M. Z., & Fleischer, B. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90208-9 · Cited by 25
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis
Chen, Z., Bozec, A., Ramming, A., & Schett, G. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0109-2 · Cited by 719
The role of the chondrocyte in osteoarthritis
Goldring, M. B. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<1916::aid-anr2>3.0.co;2-i · Cited by 713
Crawley, E., Kay, R., Sillibourne, J., Patel, P., Hutchinson, I., & Woo, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6<1101::aid-anr6>3.0.co;2-y · Cited by 530
Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells
Xu, D., Chan, W. L., Leung, B. P., Huang, F.-P., Wheeler, R., Piedrafita, D., Robinson, J. H., & Liew, F. Y. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.787 · Cited by 512
Metadata
- Authors
- Joosten, L. A. B., Lubberts, E., Durez, P., Helsen, M. M. A., Jacobs, M. J. M., Goldman, M., & van den Berg, W. B.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1997-02
- Volume
- 40
- Issue
- 2
- Pages
- 249-260
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2088244043
- Cited by
- 397
- References
- 53
- FWCI
- 26.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.